Blog

Osteoarthritis is a chronic joint condition that causes cartilage wear, pain, stiffness, and limited movement. Modern joint care combines professional monitoring, healthy lifestyle habits, and science-based support strategies. With a focus on innovation and an exclusive formulation, Diffucap developed ARTRODIFF PLUS®, designed to support joint health and mobility. What is osteoarthritis and what are the […]

Diffucap introduces its new packaging designed to enhance safety, accessibility and the overall patient experience. Key improvements include high contrast, larger typography, LIBRAS accessibility markers and a modern visual identity. The update reinforces the brand’s commitment to innovation and patient-centered care.

Diffucap celebrated its 50th anniversary with strong presence at the 57th CBOT 2025, unveiling its new packaging identity and launching Artrodiff Plus. The participation reinforces the company’s commitment to innovation, joint health, and the advancement of orthopedics in Brazil.

Diffucap celebrates its 50th anniversary with a rebranding and appoints Martin Gold as its new president. With experience at SolarMente, Metyis, and Techint, he steps in with a focus on innovation and brand identity strengthening.

Diffucap celebrates its 50th anniversary with a complete rebranding, new positioning, and a new president. The company introduces a modern visual identity, more accessible packaging, and prepares to enter the OTC market. Under Martin Gold’s leadership, the strategic shift was celebrated at Christ the Redeemer, illuminated in purple.

Nimesulide is an effective anti-inflammatory drug but may cause gastrointestinal, liver, skin, and cardiovascular side effects. Reading the leaflet and consulting a doctor is essential for safe use. Artflex Retard is a reliable nimesulide-based option for pain and inflammation relief.